Clinical Trial Update: IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating BI 765845 in people who have had a myocardial infarction has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• BI 765845

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myocardial Infarction | Phase 2 | Status: TERMINATED